Most common adverse events at least possibly related to treatment (percent of patients having event)
| Adverse event . | Grade . | |||
|---|---|---|---|---|
| 1 . | 2 . | 3 . | 4 . | |
| Thrombocytopenia | 23 | 18 | 18 | 9 |
| Anemia | 9 | 55 | 5 | 0 |
| Neutropenia | 5 | 14 | 27 | 18 |
| Rash | 18 | 23 | 18 | 0 |
| Edema | 18 | 27 | 9 | 0 |
| Infection | 0 | 27 | 18 | 0 |
| Constipation | 27 | 9 | 0 | 0 |
| Diarrhea | 27 | 14 | 0 | 0 |
| Dyspnea | 27 | 5 | 9 | 0 |
| Fatigue | 0 | 14 | 18 | 0 |
| AST | 14 | 9 | 5 | 0 |
| Hypocalcemia | 0 | 14 | 9 | 0 |
| Elevated creatinine level | 9 | 14 | 0 | 0 |
| Low consciousness/cognitive disorder | 0 | 14 | 5 | 0 |
| Neurosensory | 23 | 0 | 0 | 0 |
| Elevated alkaline phosphatase/bilirubin level | 0 | 0 | 5 | 0 |
| Dyspepsia | 0 | 5 | 9 | 0 |
| Hyperkalemia | 0 | 9 | 0 | 0 |
| Hypothyroidism | 5 | 5 | 0 | 0 |
| Muscle weakness | 0 | 14 | 0 | 0 |
| Thrombosis | 0 | 0 | 9 | 0 |
| Adverse event . | Grade . | |||
|---|---|---|---|---|
| 1 . | 2 . | 3 . | 4 . | |
| Thrombocytopenia | 23 | 18 | 18 | 9 |
| Anemia | 9 | 55 | 5 | 0 |
| Neutropenia | 5 | 14 | 27 | 18 |
| Rash | 18 | 23 | 18 | 0 |
| Edema | 18 | 27 | 9 | 0 |
| Infection | 0 | 27 | 18 | 0 |
| Constipation | 27 | 9 | 0 | 0 |
| Diarrhea | 27 | 14 | 0 | 0 |
| Dyspnea | 27 | 5 | 9 | 0 |
| Fatigue | 0 | 14 | 18 | 0 |
| AST | 14 | 9 | 5 | 0 |
| Hypocalcemia | 0 | 14 | 9 | 0 |
| Elevated creatinine level | 9 | 14 | 0 | 0 |
| Low consciousness/cognitive disorder | 0 | 14 | 5 | 0 |
| Neurosensory | 23 | 0 | 0 | 0 |
| Elevated alkaline phosphatase/bilirubin level | 0 | 0 | 5 | 0 |
| Dyspepsia | 0 | 5 | 9 | 0 |
| Hyperkalemia | 0 | 9 | 0 | 0 |
| Hypothyroidism | 5 | 5 | 0 | 0 |
| Muscle weakness | 0 | 14 | 0 | 0 |
| Thrombosis | 0 | 0 | 9 | 0 |